NCT04440410 Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis Status COMPLETED Phase N/A
NCT04414514 Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment Status TERMINATED Phase PHASE2
NCT04325607 Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa Status TERMINATED Phase NA
NCT04249713 An Alternative Dose Interval Study in Participants With Hidradenitis Suppurativa Receiving Brodalumab Status WITHDRAWN Phase EARLY_PHASE1
NCT04242498 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT04242446 A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT04200690 Effectiveness of Interdisciplinary Care Compared to Usual Care in Patients With Immune-Mediated Inflammatory Diseases Status UNKNOWN Phase NA
NCT04179175 Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04132388 Hidradenitis Suppurativa Patient Experience With Humira Treatment Status WITHDRAWN Phase PHASE4
NCT04115566 Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository Status RECRUITING Phase N/A
NCT04084665 Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. Status WITHDRAWN Phase EARLY_PHASE1
NCT04061395 Guselkumab for Hidradenitis Suppurativa, a Mode of Action Study. Status COMPLETED Phase PHASE2